Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neutrophil extracellular trap nucleic acid scaffolds are chromatin-based networks extruded by activated neutrophils that serve both protective roles in pathogen clearance and potentially harmful roles in inflammation-driven diseases. Their unique structure—a combination of decondensed genomic DNA decorated with potent antimicrobial proteins—makes them central players at the intersection between innate immunity and immunopathology.
DNases degrade the nucleic acid backbone, disrupting NET structure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutrophil Extracellular Trap Nucleic Acid Scaffolds (NET DNA).